Cellular host factors for SARS-CoV-2 infection (Q108396446)

1

0 references

Els Vanstreels

2

0 references

Sander Jansen

3

0 references

Dirk Daelemans

Coronaviruses: an overview of their replication and pathogenesis.

4

0 references

publication date

1 September 2021

0 references

published in

Nature Microbiology

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Host Factors in Coronavirus Replication

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A functional role for TorsinA in herpes simplex virus 1 nuclear egress

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The E3 Ubiquitin Ligase SIAH1 Targets MyD88 for Proteasomal Degradation During Dengue Virus Infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Cholesterol Handling in Lysosomes and Beyond

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

TMEM41B Is a Pan-flavivirus Host Factor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The SARS-CoV-2 RNA-protein interactome in infected human cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The SARS-CoV-2 RNA interactome

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Rab7A is required for efficient production of infectious HIV-1

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Immune signaling by RIG-I-like receptors

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Murine Hepatitis Virus Nonstructural Protein 4 Regulates Virus-Induced Membrane Modifications and Replication Complex Function

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Nuclear proteins hijacked by mammalian cytoplasmic plus strand RNA viruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A role for retromer in hepatitis C virus replication

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

EMC1-dependent stabilization drives membrane penetration of a partially destabilized non-enveloped virus

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A CRISPR toolbox to study virus-host interactions

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Structure, Function, and Evolution of Coronavirus Spike Proteins

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The major cellular sterol regulatory pathway is required for Andes virus infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A contemporary view of coronavirus transcription.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Accessory proteins of SARS-CoV and other coronaviruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

MAVS Coordination of Antiviral Innate Immunity.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Tom70 mediates activation of interferon regulatory factor 3 on mitochondria

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Localized Phosphorylation of a Kinesin-1 Adaptor by a Capsid-Associated Kinase Regulates HIV-1 Motility and Uncoating

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Exo70 interacts with the Arp2/3 complex and regulates cell migration

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The Regulation of Translation in Alphavirus-Infected Cells.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Endogenous Cellular MicroRNAs Mediate Antiviral Defense against Influenza A Virus.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The intracellular sites of early replication and budding of SARS-coronavirus

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The Role of Host Cholesterol During Flavivirus Infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A pneumonia outbreak associated with a new coronavirus of probable bat origin

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Origin and evolution of pathogenic coronaviruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Function of Torsin AAA+ ATPases in Pseudorabies Virus Nuclear Egress

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Endosomal Retrieval of Cargo: Retromer Is Not Alone

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

TMEM41B is a novel regulator of autophagy and lipid mobilization

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Master Regulator Analysis of the SARS-CoV-2/Human Interactome

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Coronavirus membrane fusion mechanism offers as a potential target for antiviral development

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The Architecture of SARS-CoV-2 Transcriptome

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Multiorgan and Renal Tropism of SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A molecular pore spans the double membrane of the coronavirus replication organelle

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Molecular Architecture of the SARS-CoV-2 Virus

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Neuropilin-1 is a host factor for SARS-CoV-2 infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Coronavirus biology and replication: implications for SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A SARS-CoV-2 – host proximity interactome

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A SARS-CoV-2 BioID-based virus-host membrane protein interactome and virus peptide compendium: new proteomics resources for COVID-19 research

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Transferrin receptor is another receptor for SARS-CoV-2 entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Coronavirus entry: how we arrived at SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Identification of ACE2 modifiers by CRISPR screening

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Kidney injury molecule-1 is a potential receptor for SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Genetic architecture of host proteins involved in SARS-CoV-2 infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Characterization and functional interrogation of SARS-CoV-2 RNA interactome

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Fatty Acid Synthase inhibition prevents palmitoylation of SARS-CoV2 Spike Protein and improves survival of mice infected with murine hepatitis virus

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0

The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/s41564-021-00958-0